Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06939413 · ClinicalTrials.gov registry record · NA

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

A NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by Diabetes Solutions International.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06939413 is a NA study of Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by Diabetes Solutions International. The registered enrollment target is 40 participants, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06939413, a NA study of Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by Diabetes Solutions International.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care. The main questions it aims to answer are: Does use of CGM \& RPM improve A1c? Does use of CGM \& RPM improve the percent of time spent with glucose levels between 70-180 mg/dl? Does the diabetes care management program improve diabetes related distress? Participants enrolled in the study will be wearing a CGM. Participants will be able to see the glucose readings from the CGM and see how their glucose level responds to food, physical activity, medications and daily life. The diabetes primary care team will be remotely monitoring the participant's glucose data from the CGM. They will reach out to the participant to make adjustments in treatment regimen as needed. Participants will answer a "Problem Areas in Diabetes"questionnaire that asks questions about diabetes related distress.

Conditions Studied

Type 2 Diabetes Mellitus (T2DM)

Interventions

  • DEVICE Continuous glucose monitor (CGM)

Study Locations (1)

Massachusetts

  • Community Health Center of Franklin County - Greenfield

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-18
Est. Completion 2026-10
Phase NA

Sponsor

Diabetes Solutions International

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06939413

The ClinicalTrials.gov registry entry for NCT06939413 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The listed sponsor is Diabetes Solutions International, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor (CGM) is the first listed.

NCT06939413 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06939413 about?

NCT06939413 is a clinical study titled "Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations". The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. Th...

What is the current status of trial NCT06939413?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-18. Estimated completion is 2026-10.

What conditions does trial NCT06939413 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM).

What interventions are being tested in trial NCT06939413?

The interventions under investigation include: Continuous glucose monitor (CGM) (DEVICE).

Who is sponsoring clinical trial NCT06939413?

This trial is sponsored by Diabetes Solutions International, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06939413 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes Mellitus (T2DM)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes Mellitus (T2DM)

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.